Category Archives: OGN

Assessing the Impact of the Organon Spin-Off on Merck

Posted on April 28, 2021 by Stephen Percoco

Merck is progressing toward the spin-off of its subsidiary, Organon & Co., which is expected to be completed by the end of the June.  Organon will include Merck’s women’s health products, biosimilars and certain established brands, most of which have … Continue reading →

Posted in Health Care, MRK, OGN | Tagged , , , | Leave a comment

Merck Spin-Off of Organon Targeted for 21Q2

Posted on April 15, 2021 by Stephen Percoco

In recent weeks, Merck has been following through on its plan to spin-off its subsidiary, Organon & Co., to shareholders.  On March 17, it filed its Form 10 registration statement related to the transaction.  On March 24, it posted on … Continue reading →

Posted in Health Care, MRK, OGN | Tagged , , | Leave a comment